Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Assets Average: 2011-2025

Historic Assets Average for Fennec Pharmaceuticals (FENC) over the last 15 years, with Sep 2025 value amounting to $47.1 million.

  • Fennec Pharmaceuticals' Assets Average fell 22.89% to $47.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.1 million, marking a year-over-year decrease of 22.89%. This contributed to the annual value of $35.9 million for FY2024, which is 33.47% up from last year.
  • Per Fennec Pharmaceuticals' latest filing, its Assets Average stood at $47.1 million for Q3 2025, which was up 3.13% from $45.6 million recorded in Q2 2025.
  • Fennec Pharmaceuticals' Assets Average's 5-year high stood at $66.2 million during Q2 2024, with a 5-year trough of $17.4 million in Q2 2022.
  • In the last 3 years, Fennec Pharmaceuticals' Assets Average had a median value of $45.7 million in 2025 and averaged $41.2 million.
  • Its Assets Average has fluctuated over the past 5 years, first plummeted by 37.94% in 2022, then surged by 220.80% in 2024.
  • Quarterly analysis of 5 years shows Fennec Pharmaceuticals' Assets Average stood at $27.1 million in 2021, then fell by 15.05% to $28.7 million in 2022, then declined by 18.33% to $23.4 million in 2023, then skyrocketed by 121.74% to $51.9 million in 2024, then declined by 22.89% to $47.1 million in 2025.
  • Its last three reported values are $47.1 million in Q3 2025, $45.6 million for Q2 2025, and $45.7 million during Q1 2025.